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Abstract
Background: The human T-cell leukemia virus type I (HTLV-I) basic leucine-zipper factor (HBZ)
has previously been shown to modulate transcriptional activity of Jun family members. The
presence of a novel isoform of HBZ, termed HBZ-SP1, has recently been characterized in adult T-
cell leukemia (ATL) cells and has been found to be associated with intense nuclear spots. In this
study, we investigated the role of these nuclear bodies in the regulation of the transcriptional
activity of JunB.
Results: Using fluorescence microscopy, we found that the HBZ-SP1 protein localizes to intense
dots corresponding to HBZ-NBs and to nucleoli. We analyzed the relative mobility of the EGFP-
HBZ-SP1 fusion protein using fluorescence recovery after photobleaching (FRAP) analysis and
found that the deletion of the ZIP domain perturbs the association of the HBZ-SP1 protein to the
HBZ-NBs. These data suggested that HBZ needs cellular partners, including bZIP factors, to form
HBZ-NBs. Indeed, by cotransfection experiments in COS cells, we have found that the bZIP factor
JunB is able to target delocalized form of HBZ (deleted in its nuclear localization subdomains) into
the HBZ-NBs. We also show that the viral protein is able to entail a redistribution of JunB into the
HBZ-NBs. Moreover, by transfecting HeLa cells (known to express high level of JunB) with a vector
expressing HBZ-SP1, the sequestration of JunB to the HBZ-NBs inhibited its transcriptional
activity. Lastly, we analyzed the nuclear distribution of HBZ-SP1 in the presence of JunD, a Jun
family member known to be activated by HBZ. In this case, no NBs were detected and the HBZ-
SP1 protein was diffusely distributed throughout the nucleoplasm.
Conclusion: Our results suggest that HBZ-mediated sequestration of JunB to the HBZ-NBs may
be causing the repression of JunB activity in vivo.
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Background
Human T-cell leukemia virus type I (HTLV-I) is an onco-
genic retrovirus etiologically associated with the develop-
ment of adult T-cell leukemia (ATL) [1,2]. The
mechanisms behind leukemogenesis are not yet fully
understood but it seems that several events in HTLV-I-
infected cells are required for the development of the full
malignant phenotype. Among them, the expression of the
viral Tax protein plays a crucial role in the first steps of the
process [3,4]. Tax has the ability to deregulate the tran-
scription of genes and signaling pathways involved in cel-
lular proliferation, cell cycle control and apoptosis,
including deregulation of the activator protein-1 (AP-1),
nuclear factor-κB, and E2F pathways [5].
AP-1 represents a dimeric protein, consisting of
homodimers and heterodimers composed of basic region-
leucine zipper (bZIP) proteins. AP-1 can be formed
through either homodimerization of Jun proteins (c-Jun,
JunB, and JunD) or heterodimerization of Jun and Fos
proteins (c-Fos, FosB, Fra-1, and Fra-2) via their respective
ZIP domain [6]. In addition, Jun proteins can het-
erodimerize with different members of the bZIP protein
family including the dimerization partners JDP1 and
JDP2 [7], activating transcription factors [8], and Maf pro-
teins [9]. In unstimulated T cells, the basal protein level of
AP-1 is low but there is a rapid induction of AP-1 activity
after T-cell stimulation. The IL-2 gene was one of the first
T-cell-specific genes shown to have an AP-1 site within its
promoter [10]. The AP-1 transcription complex has been
shown to be involved in the regulation of IL-2 gene
expression in combination with other transcription fac-
tors [11]. The production of IL-2 by activated T cells is crit-
ical for T-cell proliferation and differentiation, and the
development of T-cell-dependent immune responses.
Over the recent years, a large quantity of data has accumu-
lated demonstrating the contribution of AP-1 to the regu-
lation of numerous cellular genes involved in lymphocyte
activation.
AP-1 is also involved in the dysregulated phenotypes of T
cells infected with HTLV-I [12,13]. Previous studies have
shown that T-cell lines infected by HTLV-I express high
levels of AP-1 activity [14,15] with increased levels of
mRNAs coding for c-Jun, JunB, JunD, c-Fos, and Fra-1
[16,17]. Indeed, Tax can induce the expression of the
genes encoding c-Fos, Fra-1, c-Jun, and JunD [16,18]. In
addition, it has been recently demonstrated that Tax
enhances AP-1 activity at the post-transcriptional level by
activating protein kinase B [19]. Moreover, AP-1-binding
sites have been shown to be responsive elements targeted
by Tax in different cellular genes such as fra-1 and IL-2
[20,21]. On the other hand, most of ATL cells do not
express significant level of Tax in vivo suggesting that con-
stitutive activation of AP-1 in leukemic cells is likely Tax
independent [15], although it cannot be completely
excluded that a trace amount of Tax may be sufficient for
AP-1 activation. However, recent data have suggested the
involvement of another viral protein in the regulation of
AP-1 activity, i.e. the HTLV-I bZIP factor (HBZ) [22].
Unlike Tax, HBZ is encoded by the complementary strand
of the HTLV-I genome [23]. Various transcripts initiate
from the 3' long terminal repeat (LTR) of the proviral
DNA allowing the production of different isoforms of
HBZ [24,25]. These isoforms share about 95% amino acid
sequence identity and differ only at their N termini. How-
ever, the most abundant HBZ form detected in ATL cell
lines corresponds to the 206 amino acid-long isoform
[24,26] produced from the alternative spliced variant,
which we have termed HBZ-SP1 [25]. This messenger
RNA can be detected in numerous infected cell lines [25-
27] and directly in cells isolated from infected patients
[24-26]. The HBZ protein has been described to enhance
infectivity and persistence in HTLV-I-inoculated rabbits
[28], an observation which might be consequential to the
down-regulating ability of HBZ on Tax-dependent viral
transcription [23]. HBZ (Fig. 1A) is a prototypical bZIP
transcriptional factor [23] with an N-terminal transcrip-
tional activation domain, a central domain involved in
nuclear localization, and a C-terminal bZIP domain [29].
HBZ interacts with c-Jun [30,31], JunB [30], and JunD
[32] through its bZIP domain. On the other hand, HBZ is
unable to interact with c-Fos [31] or to form stable
homodimers [30]. The interaction of HBZ with c-Jun
leads to a reduction in c-Jun DNA-binding activity [33]
and prevents this protein from activating transcription of
AP-1-dependent promoters and the HTLV-I promoter (at
the basal level) [30]. We have recently demonstrated that
the HBZ-SP1 isoform was also able to down-regulate viral
expression and to inhibit c-Jun-mediated transcription
[25] as already described for the original HBZ isoform.
In this paper, we describe the nuclear distribution of the
new HBZ isoform and we show that the HBZ-SP1 protein
not only accumulates in particular nuclear bodies (called
here HBZ-NBs) as already described for the original HBZ
isoform, but that it is also targeted to nucleoli. Moreover,
we have studied the in vivo nuclear dynamics of the HBZ-
NBs through fluorescence recovery after photobleaching
(FRAP) experiments on cells transfected with the expres-
sion vector encoding HBZ-SP1 fused to the enhanced-
green-fluorescent protein (EGFP). We have observed that
the rate of nuclear flux of the HBZ-SP1 protein is altered
by the deletion of its leucine zipper domain, suggesting
that its heterodimerization partners are involved in con-
trolling its own nuclear trafficking. Indeed, by cotransfec-
tion experiments in COS cells, we have found that JunB
targets a mutated and delocalized form of HBZ into the
HBZ-NBs. In addition, we show that HBZ-SP1 also modi-Retrovirology 2007, 4:14 http://www.retrovirology.com/content/4/1/14
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fies the localization of exogenous JunB in cotransfected
COS cells and targets JunB to the HBZ-NBs. Moreover, we
demonstrate in HeLa cells (known to have high expres-
sion level of JunB) that the relocalization of endogenous
JunB by HBZ-SP1 into HBZ-NBs inhibits its transcrip-
tional activity. Taken together, these results clearly dem-
onstrate that HBZ-mediated sequestration of JunB to
these particular subnuclear structures may result in repres-
sion of JunB activity.
Results
The HBZ-SP1 isoform shows a characteristic nuclear 
distribution
It has recently been shown that the HBZ-SP1 isoform was
preferentially expressed in ATL cell lines [24]. For this rea-
son, it was of high interest to investigate the subnuclear
distribution of this protein in vivo. COS cells were trans-
fected with vectors expressing the original HBZ and HBZ-
SP1 isoforms tagged with the Myc epitope fused to its C-
terminal end. As shown in (Fig. 1A, a and 1A, b), the sub-
nuclear distribution of the HBZ-SP1 isoform exhibits a
NB-associated granular distribution as already described
for the original HBZ isoform [29]. We had also shown that
this particular nuclear distribution did not correspond to
the splicing factor compartments [29]. To determine
whether it was also the case for the HBZ-SP1 protein, we
next checked the staining pattern of HBZ-SP1 (tagged with
EGFP fused to its N-terminus) with that seen in the same
cell stained with anti-SC35, an antibody that recognizes
one component of an active spliceosome. We found that
the HBZ-SP1 isoform did not colocalize with the endog-
enous SC35 (Fig. 1B).
On the other hand, in the majority of transfected cells, the
HBZ-SP1 protein showed a distinct staining pattern when
compared to the specific nuclear staining by the original
Subcellular localization of HBZ-SP1 Figure 1
Subcellular localization of HBZ-SP1. (A) Subnuclear localization of the HBZ-SP1 protein in transfected COS cells. The 
original HBZ (a) and HBZ-SP1 (b and c) isoforms fused to the Myc epitope were transiently transfected into COS cells. Cells 
were cultivated on glass slides, fixed and treated with Vectashield containing DAPI for direct observation by fluorescence 
microscopy. For immunofluorescence analysis, the anti-Myc antibody was detected with goat anti-mouse IgG antibody coupled 
to FITC. (B) HBZ-SP1 does not colocalize with endogenous SC35. COS cells transfected with pEGFP-HBZ-SP1 were labelled 
with a mouse anti-SC35 antibody and detected using goat anti-mouse IgG antibody coupled to Texas Red. Analysis of the 
green, red, and merged fluorescent signals was performed by fluorescence microscopy. The white bars correspond to a scale 
of 10 µm.Retrovirology 2007, 4:14 http://www.retrovirology.com/content/4/1/14
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HBZ isoform. Indeed, in addition to the HBZ-NBs, we
observed intense spots in the nuclei in structures resem-
bling nucleolus organizing regions (Fig. 1A, c). Colocali-
zation experiments carried out with an anti-nucleolin
antibody effectively confirmed that the HBZ-SP1 protein
was partly localized to the nucleoli (Fig. 2).
FRAP analysis of the subnuclear transport of HBZ-SP1
The relative intracellular mobility of the EGFP-HBZ-SP1
fusion protein was examined using FRAP analysis. COS
cells were transiently transfected with pEGFP-HBZ-SP1
and a defined area in the nucleoplasm of cells expressing
the protein was photobleached. Recovery of the fluores-
cent signal in the entire bleached area was determined by
capturing sequential images following photobleaching
(Fig. 3). The estimated half-time for signal recovery of
EGFP-HBZ-SP1 was 11.5 ± 1.5 s (n = 10) and the mean
percentage of mobile fraction was 34.0 ± 3.1%. We also
observed that the nuclear foci containing EGFP-HBZ-SP1,
when recovered after photobleaching, retained the mor-
phology and the nuclear location observed before pho-
tobleaching (Fig. 3). These findings were reproduced in
three independent experiments. On the other hand, when
a defined area in nucleoli containing EGFP-HBZ-SP1 pro-
Molecular structures and nuclear localizations of HBZ-SP1 and its deletion mutants fused to EGFP Figure 2
Molecular structures and nuclear localizations of HBZ-SP1 and its deletion mutants fused to EGFP. HBZ is com-
posed of an N-terminal activation domain (AD), two basic regions (BR1 and BR2) involved in its nuclear transport, a transcrip-
tional modulatory domain (MD), and a C-terminal bZIP domain. The HBZ-SP1 protein and its mutants fused to EGFP were 
transiently transfected into COS cells (column EGFP). Cells were cultivated on glass slides, fixed and treated with Vectashield 
containing DAPI for direct observation by fluorescence microscopy. Transfected COS cells were also labelled with a mouse 
anti-nucleolin antibody (column anti-nucleolin) and detected using goat anti-mouse IgG antibody coupled to Texas Red. Analy-
sis of the green, red, and merged fluorescent (column merge) signals was performed by fluorescence microscopy. The white 
bars correspond to a scale of 10 µm.Retrovirology 2007, 4:14 http://www.retrovirology.com/content/4/1/14
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tein was photobleached, the mean percentage of mobile
fraction of EGFP-HBZ-SP1 was 90.0 ± 10.0% (data not
shown). Moreover, the EGFP control (corresponding to
EGFP alone) was observed to be completely mobile (data
not shown), confirming that EGFP mobility was modified
by its fusion with HBZ-SP1.
To determine the influence of HBZ-SP1 cellular partners
on its intracellular mobility, we decided to perform FRAP
analysis with EGFP fused to the mutant HBZ-SP1∆ZIP.
Interestingly, compared with the wild type, the mutant
showed a different pattern of staining since HBZ-
SP1∆ZIP-associated structures were more diffuse. As
shown in Fig. 2, colocalization experiments carried out
with an anti-nucleolin antibody demonstrated that these
nuclear structures corresponded to nucleoli displaying a
branching structure. These data suggest that the integrity
of the viral protein is required for the formation of the
HBZ-NBs. Moreover, while the estimated half-time for sig-
nal recovery was the same for EGFP-HBZ-SP1 and EGFP-
HBZ-SP1∆ZIP, the mean percentage of mobile fraction of
EGFP-HBZ-SP1∆ZIP only was 16.4 ± 1.5% (Fig. 3). The
decreased mobility of the HBZ-SP1∆ZIP protein com-
pared with the full-length protein also suggested that dele-
tion of the ZIP domain perturbs the intracellular mobility
of HBZ-SP1 protein. In conclusion, one plausible inter-
pretation for these observations is that HBZ needs cellular
partners, including bZIP factors, to form HBZ-NBs.
Association of HBZ-SP1 with JunB is involved in the 
formation of HBZ-NBs
To confirm that cellular proteins might be involved in
HBZ-NBs formation, we studied the subcellular localiza-
tion of an HBZ mutant deleted in its N-terminal region
The HBZ-SP1 protein dynamically associates with subnuclear foci in living cells in a C-terminus-dependent mechanism Figure 3
The HBZ-SP1 protein dynamically associates with subnuclear foci in living cells in a C-terminus-dependent 
mechanism. COS cells were transiently transfected with EGFP-HBZ-SP1 or EGFP-HBZ-SP1∆ZIP. Pre-bleached images are 
shown. The arrows show the photobleached foci for which the recovery rates were determined. The images shown were cap-
tured before photobleaching (Pre-bleach) and at the indicated time points (Post-bleach). The white bars correspond to a scale 
of 10 µm. Recovery curves of the proteins are shown as relative fluorescence intensity vs. time.Retrovirology 2007, 4:14 http://www.retrovirology.com/content/4/1/14
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while retaining the amino acid sequence from residues
120 to 206 (still containing the C-terminal domain able
to interact with bZIP factors). This mutant fused to EGFP
(EGFP-HBZ bZIP; Fig. 2) exhibited a staining pattern
identical to that of EGFP (compare Fig. 4a and 4b), with a
diffuse distribution throughout the cytoplasm and the
nucleus. This observation was expected since we have pre-
viously shown that HBZ possesses two basic regions BR1
and BR2 (Fig. 2) involved in its nuclear transport located
upstream from the bZIP domain but absent in HBZ bZIP
[29]. The localization of this mutant was then analyzed in
the presence of JunB. This cellular factor was specifically
chosen for these analyses since the effect of HBZ on JunB
activity still remains unclear. In fact, while HBZ decreases
JunB DNA-binding activity in vitro, HBZ surprisingly stim-
ulates the collagenase promoter activity in the presence of
JunB in CEM cells [30]. However, this activation is very
weak and dose-independent suggesting that it could be
due to an HBZ-dependent stimulation of an endogenous
cellular factor, which binds to the collagenase promoter,
i.e. JunD [34]. Moreover, JunB showed a diffuse pattern in
the nuclei of transfected COS cells, which was easy to dis-
criminate from the HBZ-NB pattern (Fig. 4c). Interest-
ingly, when COS cells were co-transfected with HBZ bZIP
and JunB expression vectors, both proteins were modified
in their cellular distribution (Fig. 4d–f). Indeed, they colo-
calized in nuclear spots, which are similar to that observed
in the nuclei after cotransfection of COS cells with JunB
and the wild type HBZ-SP1 (4g–i). It is worth noting that
we have previously described such a staining pattern for
JunB in the presence of the original HBZ isoform [30]. In
addition, while JunB did not modify the staining pattern
of the EGFP control (Fig. 4j–l), the EGFP-HBZ bZIP stain-
ing was reduced in the cytoplasm in the presence of JunB
(compare Fig. 4b with Fig. 4d). Altogether, these results
show that the presence of JunB leads to the nuclear accu-
mulation of HBZ bZIP and that the association of both
proteins is involved their targeting into NBs. They also
confirm that cellular partners of HBZ are involved in its
nuclear trafficking.
To be sure that the nuclear spots formed in the presence of
JunB and HBZ bZIP corresponded to HBZ-NBs induced by
HBZ-SP1, we analyzed the localization of the different
proteins in COS cells transfected with pcDNA-JunB and
pEGFP-HBZ bZIP in the absence or in the presence of
pcDNA-HBZ-SP1-Myc by fluorescence microscopy. Using
this approach, an anti-JunB antibody was not needed to
detect JunB. Indeed, the cotransfected cells were easily
characterized by the presence of nuclear spots visualized
by the green fluorescence due to the targeting of EGFP-
HBZ bZIP by JunB into specific NBs (compare Fig. 4b with
4d or Fig. 5a with 5b). On the other hand, in the presence
of pcDNA-HBZ-SP1-Myc (Fig 5c–e), HBZ bZIP, JunB, and
the HBZ-SP1 protein were found to colocalize to HBZ-
NBs as judged by the yellow colour (Fig. 5e), which corre-
sponds to the merging of the green fluorescence of the
EGFP-HBZ bZIP (Fig. 5c) and the red staining of the HBZ-
SP1 protein (Fig. 5d) detected by indirect immunofluores-
cence (the mouse anti-Myc antibody is detected with
Texas Red-labelled secondary antibodies). As shown in
Fig. 5f–h, this colocalization was not be due to the inter-
action of EGFP-HBZ bZIP with the HBZ-SP1 protein,
which was expected given that HBZ is unable to form sta-
ble homodimers [30]. Taken together, our results demon-
strate that interactions between JunB and the HBZ bZIP
domain are involved in the formation of the HBZ-NBs.
HBZ-NBs are involved in the repression of JunB activity by 
HBZ-SP1
We have previously suggested that the original HBZ iso-
form might down-regulate transcription activity of cellu-
lar partners by their sequestration in transcriptionally
inactive nuclear sites [29]. Therefore, we next conducted a
comparison between the staining pattern induced by
EGFP-HBZ bZIP, JunB and anti-human RNA polymerase
antibody specific for Ser-1801 phosphorylated RNA
polymerase II (active form). In cotransfected COS cells,
we found that endogenous RNA polymerase II did not
colocalize with the HBZ-NBs (Fig. 6). On the other hand,
in the absence of the viral protein, we found that JunB
colocalized with the active form of RNA polymerase II
(data not shown). We also examined the subnuclear local-
ization of the full-length HBZ-SP1 protein not only with
RNA polymerase II but also with proteins known to be
associated with transcriptional active sites such as Tax,
SC35, and the promyelocytic leukemia protein (PML). No
colocalization with all these proteins was observed (Fig.
1B and data not shown). Taken together, these results sug-
gest the HBZ-SP1 protein might inhibit JunB activity
through its sequestration into HBZ-NBs.
Human papillomavirus type 18 (HPV-18) mediates HeLa
cell proliferation by two oncoproteins, E6 and E7 [35],
whose expression is under the control of the early pro-
moter P105 located within the HPV-18 long control
region (LCR). Interestingly, it has been demonstrated that
P105 is controlled in HeLa cells by an enhanceosome
functionally based on a central AP-1 site, which specifi-
cally binds the JunB/Fra-2 heterodimer [36]. For this rea-
son, HeLa represented an ideal cell line to study the in vivo
effects of the HBZ-SP1 protein on JunB transcriptional
activity. We first tested the effects of the HBZ-SP1 protein
on HPV-18 transcription in the presence of exogenous
JunB. HeLa cells were cotransfected with the reporter plas-
mid pLCR-Luc containing the LCR upstream of the luci-
ferase reporter gene, pcDNA-JunB and increasing amounts
of pcDNA-HBZ-SP1-Myc. As shown in Fig. 7A, the stimu-
lation of the luciferase reporter gene by exogenous JunB
was weak although this modest induction was likelyRetrovirology 2007, 4:14 http://www.retrovirology.com/content/4/1/14
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Stimulation of HBZ-NBs formation by JunB Figure 4
Stimulation of HBZ-NBs formation by JunB. COS cells were transiently transfected with EGFP (a), HBZ bZIP fused to 
EGFP (b), or JunB (c), cultivated on glass slides, fixed, and then were analyzed by fluorescence microscopy. JunB was detected 
using a mouse anti-JunB antibody and goat anti-mouse IgG antibody coupled to Texas Red. JunB was also cotransfected into 
COS cells with either EGFP-HBZ bZIP (d-f), or EGFP-HBZ-SP1 (g-i), or EGFP (j-l). Analysis of the green (a, b, d, g, and j), red 
(c, e, h, and k) and merged (f, i, and l) fluorescent signals was performed by fluorescence microscopy. The white bars corre-
spond to a scale of 10 µm.Retrovirology 2007, 4:14 http://www.retrovirology.com/content/4/1/14
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JunB and HBZ bZIP are involved in the formation of HBZ-NBs Figure 5
JunB and HBZ bZIP are involved in the formation of HBZ-NBs. COS cells were cotransfected with pcDNA-JunB and 
pEGFP-HBZ bZIP in the absence (b) or in the presence of pcDNA-HBZ-SP1-Myc (c-e). Analysis of the green (a, b, c, and f), red 
(d and g), and merged (e and h) fluorescent signals was performed by fluorescence microscopy. The HBZ-SP1 protein was 
detected using the anti-Myc antibody and the goat anti-mouse IgG antibody coupled to Texas Red. COS cells transfected with 
pEGFP-HBZ bZIP (but without JunB) in the absence (a) or in the presence of pcDNA-HBZ-SP1-Myc (f-h) were also analyzed 
through the same approach. The white bars correspond to a scale of 10 µm.Retrovirology 2007, 4:14 http://www.retrovirology.com/content/4/1/14
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related to the previously reported high expression level of
endogenous JunB in HeLa cells due to a 3-fold amplifica-
tion of the Jun-B gene [37]. In the presence of the HBZ-
SP1 protein, the stimulation of the luciferase reporter
gene was inhibited (Fig. 7A). This result was expected
since we had already demonstrated that the original HBZ
isoform led to a decrease in JunB DNA-binding activity on
the AP-1 site [30]. In light of these data, we next investi-
gated whether the HBZ-SP1 protein could affect cell cycle
progression of HeLa cells. For these analyses, HeLa cells
were transfected with pEGFP-HBZ-SP1 or pNLS-EGFP as a
negative control. 24 h after transfection, cells expressing
the HBZ-SP1 protein were separated from untransfected
cells employing FACS® cell analyzing and both popula-
tions were then subjected to cell cycle analysis by measur-
ing DNA content through propidium iodide staining and
flow cytometry. The presence of the HBZ-SP1 protein led
to the accumulation of cells in G1 in contrast to untrans-
fected cells (Fig. 7B). On the other hand, no difference was
detected between the cells expressing or not the NLS-EGFP
fusion protein (date not shown). Taken together, these
results show that the HBZ-SP1 protein is able to down-
regulate HPV-18 transcription in HeLa cells and thereby
affect cell cycle progression.
We then analyzed HPV-18 transcription, cell cycle pro-
gression, and nuclear distribution of endogenous JunB in
HeLa cells transfected with either pEGFP-HBZ-SP1, two
mutants (pEGFP-HBZ∆AD and pEGFP-HBZ∆AD∆bZIP;
see Fig. 2) or pNLS-EGFP. To better analyze the effects of
these different fusion proteins on cell cycle progression,
transfected HeLa cells were arrested using a double thymi-
dine block and restimulated by serum to enter the cell
cycle. Cell cycle profiles were then analyzed at different
time points as described above with the asynchronized
HeLa cells. In contrast to untransfected cells, quiescent
cells transfected with pEGFP-HBZ-SP1 failed to progress
through the G1/S transition when they were stimulated by
serum to enter the cell cycle, (Fig. 7C). The fusion protein
deleted of its activation domain was still able to slow
down cell cycle progression since only 20.8% of cells
expressing HBZ∆A D  w e r e  i n  G 2 phase compared with
79.1% in control cells transfected with pNLS-EGFP (at 8
h) (Fig. 8A). On the other hand, an additional deletion in
the C-terminal region of the protein (pEGFP-HBZ∆AD∆
bZIP) completely abrogated the ability of HBZ-SP1 to
affect cell cycle progression (Fig. 8A). Interestingly, we
found that the EGFP-HBZ-SP1 and EGFP-HBZ∆AD fusion
proteins were able to negatively regulate P105 promoter
activity in HeLa cells, while EGFP-HBZ∆AD∆bZIP demon-
strated no repressing activity on this promoter (Fig. 8B).
In parallel, we also analyzed the nuclear distribution of
endogenous JunB in transfected HeLa cells, treated with
thymidine and restimulated by the addition of serum. In
HeLa cells expressing EGFP-HBZ-SP1 or EGFP-HBZ∆AD,
endogenous JunB was specifically targeted to HBZ-NBs
(Fig. 9A) and colocalized with the viral proteins (Fig. 9B).
On the other hand, the signal remained diffuse in control
cells transfected with pNLS-EGFP (Fig. 9A) or pEGFP-
HBZ∆AD∆bZIP (data not shown). Taken together, our
The HBZ-NBs do not colocalize with endogenous RNA polymerase II Figure 6
The HBZ-NBs do not colocalize with endogenous RNA polymerase II. COS cells cotransfected with pcDNA-JunB 
and pEGFP-HBZ bZIP were labelled with a mouse anti-RNA polymerase II antibody and detected using goat anti-mouse IgG 
antibody coupled to Texas Red. Analysis of the green, red, and merged fluorescent signals was performed by fluorescence 
microscopy. The white bars correspond to a scale of 10 µm.Retrovirology 2007, 4:14 http://www.retrovirology.com/content/4/1/14
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Effects of the HBZ-SP1 protein on HPV-18 transcription in HeLa cells Figure 7
Effects of the HBZ-SP1 protein on HPV-18 transcription in HeLa cells. (A) The HBZ-SP1 protein inhibits HPV-18 
transcription. HeLa cells (6 × 105) were cotransfected with 0.1 µg of LCR-Luc, 1 µg of pcDNA3.1(-)/Myc-His/lacZ (β-galactosi-
dase-containing reference plasmid), 0.5 µg of pcDNA-JunB, and 0, 0.5, 1, or 2 µg of pcDNA-HBZ-SP1-Myc. The luciferase val-
ues are expressed as levels of fold activation relative to luciferase activity measured in cells transfected with pcDNA3.1(-)/Myc-
His in the presence of the luciferase reporter gene without the early promoter P105. The total amount of DNA in each series 
of transfection was equal through the addition of pcDNA3.1(-)/Myc-His acting as filler DNA. Luciferase values were normalized 
for β-galactosidase activity. Values represent the mean ± S.D. (n = 3). (B) HBZ-SP1 protein expression in HeLa cells leads to 
the accumulation of cells in G1. At 24 h posttransfection, cells were harvested and GFP-positive cells (transfected with pEGFP-
HBZ-SP1) were then analyzed for DNA content as described in Materials and Methods. The DNA content of EGFP-HBZ-SP1-
transfected HeLa cells was then compared with that of untransfected cells by flow cytometry. The experiment shown here is 
representative of two independent experiments; the other experiment showed similar results. (C) The HBZ-SP1 protein 
blocks HeLa cell cycle progression through G1 phase. HeLa cells transfected or not with pEGFP-HBZ-SP1 were arrested in the 
cell cycle using a double thymidine block and restimulated with 10% FCS for the indicated times, harvested, and analyzed as 
described in panel B. The experiment shown here is representative of three independent experiments; the other two experi-
ments showed similar results.Retrovirology 2007, 4:14 http://www.retrovirology.com/content/4/1/14
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results demonstrate that the targeting of endogenous JunB
into HBZ-NBs inhibits JunB activity in HeLa cells.
The HBZ-SP1 protein does not form HBZ-NBs in the 
presence of JunD
Our data suggest that the HBZ-SP1 protein could inhibit
the activity of a transcriptional factor such as JunB by
sequestration to HBZ-NBs. HBZ is known to affect tran-
scriptional activity differently depending on its het-
erodimerization partner. For example, unlike for JunB,
HBZ stimulates JunD activity [32]. For this reason, the
nuclear distribution of the EGFP-HBZ-SP1 fusion protein
was studied in the presence of JunD. COS cells were tran-
siently cotransfected with vectors expressing the EGFP-
HBZ-SP1 fusion protein and JunD tagged with the Flag
epitope to its C-terminal end. When the JunD expression
vector was transfected alone, it localized to the nucleus in
a diffuse pattern (data not shown). When EGFP-HBZ-SP1
and JunD were coexpressed, EGFP-HBZ-SP1 was diffusely
distributed throughout the nucleus (Fig. 10). The colocal-
ization of JunD and EGFP-HBZ-SP1 in the nucleus was
visualized by yellow staining corresponding to the merg-
ing of the immunofluorescence signals for both EGFP-
HBZ-SP1 and JunD detected. This observation supports
the notion that the HBZ-SP1 protein does not target JunD
into transcriptionally-inactive NBs.
Discussion
In this paper, we have studied the nuclear distribution of
the HBZ-SP1 isoform produced from the HBZ-SP1 spliced
transcript initiated in the 3' long terminal repeat of the
HTLV-I proviral genome [24,25]. The HBZ-SP1 mRNA has
been described to be the most abundant HBZ spliced var-
iant detected in different HTLV-I-infected cell lines and
importantly in cellular clones isolated from HTLV-I-
infected patients [24-26]. In addition, by immunoblot
analyses and immunochemistry, Murata et al. have
recently demonstrated that the ATL cell lines predomi-
nantly express HBZ-SP1 isoform at the protein level [24].
They have also observed that the HBZ-SP1 protein can be
located in the nucleoli [24] in addition to its association
with particular NBs, which have been already described
for the original HBZ isoform [23]. Our data here confirm
their observations since, in transfected COS cells, the
EGFP-HBZ-SP1 fusion protein is effectively located in the
nucleoli. Moreover, although we have previously demon-
strated that the original HBZ could be associated with het-
erochromatin distributed around the nucleoli [29], we
found no association of the HBZ-SP1 protein with hetero-
chromatin markers (data not shown). The location of the
HBZ-SP1 protein in the nucleoli is not unexpected since
we have previously demonstrated that HBZ possesses two
basic regions, BR1 and BR2, positioned upstream of its
bZIP domain, which are similar in sequence to the con-
sensus nucleolar localization signal and are able to target
EGFP to nucleoli [29]. The functional role for this partic-
ular subcellular targeting remains however unclear. The
nucleolus has been described to be involved in the seques-
tration of transcription factors, such as hypoxia-inducible
factor-1α, as well as of proteins that modulate transcrip-
tion factor activity, such as Mdm2 [38,39]. Therefore, we
cannot exclude the possibility that nucleolar proteins can
regulate the function of the HBZ-SP1 protein. Conversely,
it could be suggested that the HBZ-SP1 protein might act
on nucleolar proteins, especially knowing that this viral
protein has been shown to be located in nucleoli of ATL
cell lines [24].
In addition to BR1 and BR2, a third NLS region corre-
sponding to the basic domain of the HBZ bZIP has been
characterized [29]. However, the presence of at least two
of the three NLSs is necessary for the translocation of this
protein to the nucleus. In this study, we confirm these pre-
vious observations since the EGFP-HBZ bZIP fusion pro-
tein exhibits a diffuse distribution throughout the
cytoplasm and the nucleus. On the other hand, in the
presence of JunB, nuclear accumulation of HBZ bZIP is
stimulated. Moreover, our results indicate that HBZ bZIP
is efficiently targeted into HBZ-NBs by interaction with
JunB. On the other hand, this interaction causes targeting
of both proteins into NBs and not into the nucleoli, con-
firming that BR1 and BR2 are likely to be involved in the
transport of the viral protein into the nucleoli. In addi-
tion, we find that HBZ-NBs do not colocalize with nuclear
proteins known to be associated with active transcrip-
tional sites. Effectively, in HeLa cells transfected with
EGFP-HBZ-SP1 fusion protein, we have demonstrated
that the relocalization of endogenous JunB into HBZ-NBs
is associated with repression of its activity. It is worth not-
ing that we have previously demonstrated that the DNA-
binding activity of JunB on AP-1 site is inhibited in the
presence of HBZ [30]. Taken together, our results suggest
that the HBZ-SP1 protein could inhibit JunB activity by
forming a heterodimer unable to bind to viral or cellular
promoters and by targeting JunB to HBZ-NBs. This
hypothesis is confirmed by the data obtained with JunD.
Indeed, HBZ stimulates JunD transcriptional activity [32],
does not modify its DNA-binding activity [32], and is dif-
fusely distributed throughout the nucleus in the presence
of JunD. The latter result differs from a previous study per-
formed in our laboratory. We had found that HBZ
entailed an intracellular redistribution of JunD into NBs
[32]. We speculate that this difference may be related to
the fact that JunD was tagged with RFP, which has
impaired the JunD transcriptional activity in vivo (our
unpublished data). Henceforth, it would be of high inter-
est to determine whether other nuclear proteins could be
associated with the HBZ-NBs. For the moment, we have
tested different proteins including PML, SC35, HP1α,
HP1β, HP1γ, and HMGA1a (data not shown), and noneRetrovirology 2007, 4:14 http://www.retrovirology.com/content/4/1/14
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The bZIP domain of the HBZ-SP1 protein is involved in the cell cycle arrest induced by transfection of HeLa cells with pEGFP- HBZ-SP1 Figure 8
The bZIP domain of the HBZ-SP1 protein is involved in the cell cycle arrest induced by transfection of HeLa 
cells with pEGFP-HBZ-SP1. (A) Cell cycle of HeLa cells transfected with different mutants of the HBZ-SP1 protein. HeLa 
cells were transfected with pNLS-EGFP, pEGFP-HBZ-SP1, pEGFP-HBZ∆AD, or pEGFP-HBZ∆AD∆bZIP. HeLa cells were 
arrested using a double thymidine block and restimulated with 10% FCS for the indicated times, harvested, and their DNA con-
tent was then analyzed by flow cytometry. Bars show the percentage of cells in each phase of the cell cycle. The data represent 
results from one of three independent experiments; the other two experiments showed similar results. (B) Effects of EGFP-
HBZ-SP1 and the mutants on HPV-18 transcription. HeLa cells were cotransfected with pLCR-Luc and pNLS-EGFP, pEGFP-
HBZ-SP1, pEGFP-HBZ∆AD, or pEGFP-HBZ∆AD∆bZIP. The luciferase values are expressed as levels of fold activation relative 
to luciferase activity measured in cells transfected with pcDNA3.1(-)/Myc-His in the presence of the luciferase reporter gene 
without the early promoter P105. The total amount of DNA in each series of transfection was equal, through the addition of 
pEGFP-C2 acting as filler DNA. Luciferase values were normalized for β-galactosidase activity. Values represent the mean ± 
S.D. (n = 3).Retrovirology 2007, 4:14 http://www.retrovirology.com/content/4/1/14
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Targeting of endogenous JunB to HBZ-NBs in HeLa cells transfected with pEGFP-HBZ-SP1 Figure 9
Targeting of endogenous JunB to HBZ-NBs in HeLa cells transfected with pEGFP-HBZ-SP1. (A) Nuclear localiza-
tion of endogenous JunB in HeLa cells transfected with different mutants of the HBZ-SP1 protein. HeLa cells were transfected 
with pNLS-EGFP, pEGFP-HBZ-SP1, pEGFP-HBZ∆AD. HeLa cells were arrested using a double thymidine block and restimu-
lated with 10% FCS for the indicated times and the subnuclear localization of endogenous JunB was analyzed by immunofluo-
rescence microscopy. JunB was detected using a mouse anti-JunB antibody and goat anti-mouse IgG antibody coupled to Texas 
Red. (B) Colocalization of endogenous JunB with EGFP-HBZ-SP1 and EGFP-HBZ∆AD in transfected HeLa cells arrested in the 
cell cycle. The shown data correspond to t = 0 of Fig. 9A and are representative of the experiments obtained at different times. 
Analysis of the green, red, and merged fluorescent signals was performed by fluorescence microscopy. The white bars corre-
spond to a scale of 10 µm.Retrovirology 2007, 4:14 http://www.retrovirology.com/content/4/1/14
Page 14 of 16
(page number not for citation purposes)
of these proteins demonstrated colocalization with the
HBZ-SP1 protein. These particular nuclear structures
could also correspond to sites promoting protein degrada-
tion as suggested by Matsumoto et al. [31] or protein
modification as already described for members of the pro-
tein inhibitor of activated STAT family [40]. Complemen-
tary experiments are necessary to evaluate these different
possibilities.
Conclusion
We and others have already demonstrated that the HBZ
bZIP domain is involved in the interaction with the differ-
ent members of the Jun family [30,31]. In this study, we
further extend these observations with our results on
JunB. From our studies, it is apparent that HBZ is capable
of inhibiting both c-Jun and JunB transcriptional activities
while it stimulates JunD activity. Thus, HBZ provides an
interesting model to better understand the consequences
of a dysfunction of the AP-1 pathway in T cells. Future
experiments focussed on the regulation of HBZ expression
and activity will also be of great interest. Moreover, the
identification of putative cellular genes controlled by this
novel AP-1 factor should elucidate the diverse regulatory




The vectors pcDNA-HBZ-SP1-Myc, pEGFP-HBZ-bZIP (Fig.
1A), pcDNA-JunB, pCMV-JunD-Flag have already been
described [23,25,30]. To generate the EGFP fusion pro-
teins, HBZ-SP1, HBZ-SP1∆ZIP, HBZ∆AD, and HBZ∆AD∆
bZIP DNA (Fig. 1A) were PCR amplified from the pcDNA-
HBZ-SP1-Myc vector, digested with EcoRI and BamHI, and
subcloned in frame into similarly digested pEGFP-C2
(Clontech). pEGFP-HBZ∆AD and pEGFP-HBZ∆AD∆bZIP
encode for the HBZ-SP1 protein from residues 77 to 206
and 77 to 132, respectively. pLCR-Luc and pNLS-EGFP
(corresponding to EGFP under the control of the nuclear
localization signal of SV40) is a gift from G. Steger and M.
Piechaczyk, respectively.
Fluorescence microscopy analysis
COS cells were cultured in DMEM supplemented with
10% FCS. 24 h before transfection, cells were seeded onto
glass slides. They were transfected using the jetPEI™ trans-
fection reagent (Qbiogene) according to the manufac-
turer's instructions and, after 48 h, they were washed with
PBS, fixed, and permeabilized with 4% paraformaldehyde
and 0.1% Triton ×-100 for 30 min at room temperature. If
necessary, cells were incubated with primary antibody
(mouse anti-Myc antibody 9E10 or anti-Flag, Sigma-
Aldrich; mouse anti-nucleolin, anti-JunB, or anti-RNA
polymerase II antibody, Santa Cruz Biotechnology Inc.;
the mouse anti-SC35 antibody is a gift from J. Tazi) for 1
h at room temperature. Samples were washed with PBS
and then incubated with secondary FITC- or Texas Red-
labelled antibodies (Pierce) for 1 h at room temperature.
Coverslips were mounted with Vectashield containing
DAPI (Abcys) for direct observation.
Immunofluorescence microscopy analysis of the colocalization of JunD and the HBZ-SP1 protein in vivo Figure 10
Immunofluorescence microscopy analysis of the colocalization of JunD and the HBZ-SP1 protein in vivo. COS 
cells cotransfected with pCMV-JunD-Flag and pEGFP-HBZ-SP1 were labelled with a mouse anti-Flag antibody and detected 
using goat anti-mouse IgG antibody coupled to Texas Red. Analysis of the green, red, and merged fluorescent signals was per-
formed by fluorescence microscopy. The white bars correspond to a scale of 10 µm.Retrovirology 2007, 4:14 http://www.retrovirology.com/content/4/1/14
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Fluorescence images were acquired by fluorescence micro-
scopy (model DM R; Leica) at room temperature with a
63x, NA 1.32, oil immersion objective at pinhole size 1
Airy (observation with immersion oil type DF, Cargille
Laboratories Inc.). DAPI, GFP, FITC, and Texas Red were
excited by 365-, 488-, 492-, and 596-nm laser light and
emission was detected at 420, 507, 520, and 620 nm,
respectively. The photographs were taken with a Photo
Leika DC 250 camera and the images were analyzed with
QFluoro software (Leica).
FRAP
FRAP was performed using the Zeiss LSM Meta 510 confo-
cal microscope. FRAP recoveries were acquired at 37°C on
EGFP-HBZ-SP1- or EGFP-HBZ-SP1∆ZIP-expressing cells
plated on glass coverslips. The 488-nm line of the Ar+
laser was used for the excitation of EGFP. Cells were
observed using a 63x, NA 1.2, oil immersion objective at
pinhole size 1 Airy (observation with immersion oil
Immersol™, Zeiss). After 5 prebleach scans, a region of
interest was bleached and fluorescence recovery was ana-
lyzed for 5 min. Experimental recoveries were normalized
and corrected for z-position fluctuation of cells using
another region as an internal standard.
HeLa cell transfection and luciferase assay
HeLa cells were cultured in DMEM supplemented with
10% FCS and were transfected using the jetPEI™ transfec-
tion reagent (Qbiogene). 1 µg of pcDNA3.1(-)/Myc-His/
lacZ (β-galactosidase-containing reference plasmid) was
included in each transfection to control for transfection
efficiency. The total amount of DNA in each transfection
was the same (3.6 µg) through the adequate added
amount of pcDNA3.1(-)/Myc-His. Cell extracts normal-
ized for protein content were used for luciferase and β-
galactosidase assays as already described [30].
Cell cycle analysis by flow cytometry
Cell cycle analysis was based on the measurement of
nuclear DNA content using flow cytometry and propid-
ium iodide. Briefly, HeLa cells were trypsinized, washed
with PBS, and fixed in cold 70% ethanol. After being
washed in PBS, cells were resuspended in PBS containing
0.1% Triton ×-100, 40 µg/ml propidium iodide, and 50
µg/ml RNase A. Stained cells were then processed with an
EPICS XL4C cytofluorometer (Coulter) and analyzed with
the CellCycle software. For flow cytometric analysis of
transiently transfected cells, 106 HeLa cells were trans-
fected with 5 µg of pNLS-EGFP or pEGFP-HBZ-SP1 using
the BD Calphos™ mammalian transfection kit (BD Bio-
sciences) according to the manufacturer's instructions. At
24 h posttransfection, cells were harvested and GFP-posi-
tive cells were then analyzed for DNA content with a UV
laser by the EPICS XL4C cytofluorometer (Coulter). For
analyses of S-phase entry, the cells were arrested by using
a double thymidine block. The HeLa cells were blocked
for 12h with 2,5 mM thymidine, washed with DMEM
without serum, transfected with the indicated vector and,
at 12 h posttransfection, cells were again blocked with 2,5
mM thymidine for another 12 h to arrest all cells at the
beginning of S phase. The cells were released from the thy-
midine block by three washes in fresh medium and
allowed to progress through G1 and into S phase by stim-
ulation with 10% FCS. The cell cycle positioning of
serum-stimulated cells was determined at different time
points by propidium iodide staining and flow cytometry
analysis as described above.
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